Tag: cguard embolic prevention system
January 24, 2019
InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study
InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of... January 23, 2019
InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS
InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of... January 14, 2019
InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa
InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
November 29, 2018
InspireMD’s CGuard Product Receives Approvals in Australia
Australia's regulatory agency has granted approval for the device, which prevents stroke caused by the treatment of carotid artery disease. November 28, 2018
InspireMD Announces Regulatory and Reimbursement Approval of CGuard Embolic Prevention System in Australia
InspireMD (NYSE American:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment... September 17, 2018